| 1 |
Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension
Ronald J. Raymond, Alan L. Hinderliter, Park W. Willis et al. · Journal of the American College of Cardiology
Open access |
Apr 2002 |
831 |
| 2 |
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation
Jiehui Deng et al. · Cancer Discovery
Open access |
3 Nov 2017 |
801 |
| 3 |
Rho Family GTPase Modification and Dependence on CAAX Motif-signaled Posttranslational Modification
Patrick J. Roberts, Natalia Mitin, Patricia J. Keller et al. · Journal of Biological Chemistry
Open access |
10 Jul 2008 |
370 |
| 4 |
Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector
Joshua C. Grieger, Stephen Soltys, Richard Jude Samulski · Molecular Therapy
Open access |
6 Oct 2015 |
327 |
| 5 |
Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo
Christopher C. Nixon et al. · Nature
Open access |
22 Jan 2020 |
323 |
| 6 |
Manufacturing of recombinant adeno-associated viral vectors for clinical trials
Nathalie Clément, Joshua C. Grieger · Molecular Therapy — Methods & Clinical Development
Open access |
2016 |
293 |
| 7 |
Perception of Chemotherapy Side Effects Cancer versus Noncancer Patients
Celeste M Lindley, Jeannine S. McCune, Tracy E. Thomason et al. · Cancer Practice
|
Mar 1999 |
217 |
| 8 |
Dry Powder Inhalers: An Overview
Paul J. Atkins · Respiratory Care
|
Oct 2005 |
182 |
| 9 |
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial
J.M. Weiss et al. · Annals of Oncology
Open access |
22 Aug 2019 |
174 |
| 10 |
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS- Mutant Pancreatic Cancer
Craig M. Goodwin et al. · Cancer Research
Open access |
8 Nov 2022 |
171 |
| 11 |
Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension
Alan L. Hinderliter, Park W. Willis, Walker A. Long et al. · The American Journal of Cardiology
|
Aug 1999 |
164 |
| 12 |
Assessing the Financial Value of Patient Engagement: A Quantitative Approach from CTTI’s Patient Groups and Clinical Trials Project
Bennett S. Levitan, Kenneth A. Getz, Eric L. Eisenstein et al. · Therapeutic Innovation & Regulatory Science
Open access |
20 Jul 2017 |
161 |
| 13 |
Transient CDK4/6 inhibition protects hematopoietic stem cells from chemotherapy-induced exhaustion
Shenghui He, Patrick J. Roberts, Jessica A. Sorrentino et al. · Science Translational Medicine
Open access |
26 Apr 2017 |
160 |
| 14 |
Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis
Paolo Raggi, Antonio Bellasi, David A. Bushinsky et al. · Circulation
Open access |
11 Nov 2019 |
154 |
| 15 |
Expanding the genetic architecture of nicotine dependence and its shared genetics with multiple traits
Bryan C. Quach et al. · Nature Communications
Open access |
3 Nov 2020 |
133 |
| 16 |
Preclinical Characterization of G1T28: A Novel CDK4/6 Inhibitor for Reduction of Chemotherapy-Induced Myelosuppression
John Bisi, Jessica A. Sorrentino, Patrick J. Roberts et al. · Molecular Cancer Therapeutics
|
29 Jan 2016 |
127 |
| 17 |
CDK4/6 inhibition induces epithelial cell cycle arrest and ameliorates acute kidney injury
Derek P. DiRocco, John Bisi, Patrick J. Roberts et al. · American Journal of Physiology-Renal Physiology
Open access |
12 Dec 2013 |
126 |
| 18 |
Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study
Lowell L. Hart, Renata Ferrarotto, Zoran Gojko Andric et al. · Advances in Therapy
Open access |
29 Oct 2020 |
125 |
| 19 |
Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial
Antoinette R. Tan, Gail Shaw Wright, Anu R. Thummala et al. · The Lancet Oncology
|
28 Sep 2019 |
117 |
| 20 |
From DREAM to REALITI‐A and beyond: Mepolizumab for the treatment of eosinophil‐driven diseases
Ian Douglas Pavord, Elisabeth H. Bel, Arnaud Bourdin et al. · Allergy
Open access |
17 Aug 2021 |
116 |
| 21 |
Herpesvirus Infection Accelerates Atherosclerosis in the Apolipoprotein E–Deficient Mouse
Dagmar Alber, Kenneth L. Powell, Patrick J. Vallance et al. · Circulation
Open access |
15 Aug 2000 |
106 |
| 22 |
Patient Burden and Real-World Management of Chemotherapy-Induced Myelosuppression: Results from an Online Survey of Patients with Solid Tumors
Robert S. Epstein, Matti Aapro, Upal Kunal Basu Roy et al. · Advances in Therapy
Open access |
8 Jul 2020 |
105 |
| 23 |
Step-Wise Chondrogenesis of Human Induced Pluripotent Stem Cells and Purification Via a Reporter Allele Generated by CRISPR-Cas9 Genome Editing
Shaunak Sanjay Adkar, Chia‐Lung Wu, Vincent P. Willard et al. · Stem Cells
Open access |
31 Oct 2018 |
105 |
| 24 |
CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy
Anne Y. Lai, Jessica A. Sorrentino, Konstantin H. Dragnev et al. · Journal for ImmunoTherapy of Cancer
Open access |
Oct 2020 |
92 |
| 25 |
Design of anti-inflammatory heparan sulfate to protect against acetaminophen-induced acute liver failure
Katelyn Arnold et al. · Science Translational Medicine
Open access |
18 Mar 2020 |
90 |
| 26 |
Guideline‐Directed Medical Therapy and Survival Following Hospitalization in Patients with Heart Failure
Richard H. Tran, Ahmed Mohammed Aldemerdash, Patricia P. Chang et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
Open access |
9 Feb 2018 |
90 |
| 27 |
Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive‐stage small cell lung cancer: A multicentre, randomised, double‐blind, placebo‐controlled Phase II trial
Davey B. Daniel, Vladimer Kuchava, Igor Bondarenko et al. · International Journal of Cancer
Open access |
22 Dec 2020 |
85 |
| 28 |
Frequency and severity of tricuspid regurgitation determined by Doppler echocardiography in primary pulmonary hypertension
Alan L. Hinderliter, Park W. Willis, Walker A. Long et al. · The American Journal of Cardiology
|
Apr 2003 |
85 |
| 29 |
Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies
Jared Weiss, Jerome H. Goldschmidt, Zoran Gojko Andric et al. · Clinical Lung Cancer
Open access |
26 Mar 2021 |
71 |
| 30 |
A Phase 1 study of the long‐acting anti‐IL‐5 monoclonal antibody GSK3511294 in patients with asthma
Dave Singh, Rainard Fuhr, Nicholas Bird et al. · British Journal of Clinical Pharmacology
Open access |
22 Jul 2021 |
69 |
| 31 |
Percutaneous Peripheral Nerve Stimulation (PNS) for the Treatment of Chronic Low Back Pain Provides Sustained Relief
Christopher A Gilmore, Leonardo Kapural, Meredith J. McGee et al. · Neuromodulation Technology at the Neural Interface
|
5 Oct 2018 |
66 |
| 32 |
Chemotherapy and CDK4/6 Inhibitors: Unexpected Bedfellows
Patrick J. Roberts, Vishnu Muthuraj Kumarasamy, Agnieszka Katarzyna Witkiewicz et al. · Molecular Cancer Therapeutics
Open access |
16 Jun 2020 |
63 |
| 33 |
Preclinical development of G1T38: A novel, potent and selective inhibitor of cyclin dependent kinases 4/6 for use as an oral antineoplastic in patients with CDK4/6 sensitive tumors
John Bisi, Jessica A. Sorrentino, Jamie L. Jordan et al. · Oncotarget
Open access |
15 Mar 2017 |
61 |
| 34 |
Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA ® Dry Powder Inhaler
David Prime, Wilfried De Backer, Melanie Hamilton et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery
Open access |
15 Sep 2015 |
60 |
| 35 |
IGSF8 is an innate immune checkpoint and cancer immunotherapy target
Yulong Li et al. · Cell
Open access |
23 Apr 2024 |
56 |
| 36 |
Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy‐induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials
Renata Ferrarotto, Ian C. Anderson, Balazs Medgyasszay et al. · Cancer Medicine
Open access |
18 Aug 2021 |
50 |
| 37 |
CDK4/6 Therapeutic Intervention and Viable Alternative to Taxanes in CRPC
James P. Stice, Suzanne E. Wardell, John D. Norris et al. · Molecular Cancer Research
Open access |
16 Feb 2017 |
50 |
| 38 |
G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer
Kaitlyn J. Andreano, Suzanne E. Wardell, Jennifer G. Baker et al. · Breast Cancer Research and Treatment
Open access |
4 Mar 2020 |
47 |
| 39 |
A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 µg compared with tiotropium 18 µg in patients with COPD
Gregory Feldman, François Maltais, Sanjeev K. Khindri et al. · International Journal of COPD
Open access |
Apr 2016 |
47 |
| 40 |
Utility of Adiponectin as a Biomarker Predictive of Glycemic Efficacy Is Demonstrated by Collaborative Pooling of Data From Clinical Trials Conducted by Multiple Sponsors
John A. Wagner, Elizabeth Cox Wright, Marguerite Ennis et al. · Clinical Pharmacology & Therapeutics
|
24 Jun 2009 |
44 |
| 41 |
Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II Study
Antoinette R. Tan, Gail Shaw Wright, Anu R. Thummala et al. · Clinical Cancer Research
Open access |
6 Dec 2021 |
43 |
| 42 |
Real-world burden of chemotherapy-induced myelosuppression in patients with small cell lung cancer: a retrospective analysis of electronic medical data from community cancer care providers
Robert S. Epstein, Roshanthi K. Weerasinghe, Amy S. Parrish et al. · Journal of Medical Economics
Open access |
20 Dec 2021 |
42 |
| 43 |
Cancer Patients’ Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life
Robert S. Epstein, Upal Kunal Basu Roy, Matti Aapro et al. · Patient Preference and Adherence
Open access |
Feb 2021 |
41 |
| 44 |
Randomized Trial of Clitoral Vacuum Suction Versus Vibratory Stimulation in Neurogenic Female Orgasmic Dysfunction
Marcalee Sipski Alexander, Khurram Bashir, Craig J. Alexander et al. · Archives of Physical Medicine and Rehabilitation
|
9 Sep 2017 |
36 |
| 45 |
[18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant
Ramsha Iqbal, Maqsood M. Yaqub, Huseyyin O. Bektas et al. · Clinical Cancer Research
Open access |
3 Feb 2023 |
35 |
| 46 |
Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype
Benjamin Terrier, David R.W. Jayne, Bernhard Hellmich et al. · ACR Open Rheumatology
Open access |
13 Jun 2023 |
34 |
| 47 |
Percutaneous Peripheral Nerve Stimulation for the Treatment of Chronic Low Back Pain: Two Clinical Case Reports of Sustained Pain Relief
Leonardo Kapural, Christopher A Gilmore, John Chae et al. · Pain Practice
|
14 Mar 2017 |
33 |
| 48 |
Glucose and lipid effects of the ileal apical sodium‐dependent bile acid transporter inhibitor GSK2330672 : double‐blind randomized trials with type 2 diabetes subjects taking metformin
Derek J. Nunez, Xiaozhou Yao, Jian Lin et al. · Diabetes Obesity and Metabolism
|
5 Mar 2016 |
33 |
| 49 |
Pharmacokinetics of Oral Treprostinil Sustained Release Tablets During Chronic Administration to Patients with Pulmonary Arterial Hypertension
R. James White, Fernando Torres, Roblee P. Allen et al. · Journal of Cardiovascular Pharmacology
|
17 Jan 2013 |
32 |
| 50 |
Initial locomotor sensitivity to cocaine varies widely among inbred mouse strains
Tim Wiltshire, Robin Ervin, Huicun Duan et al. · Genes Brain & Behavior
Open access |
Mar 2015 |
32 |